References
- Schiavoni G, Gabriele L, Mattei F. The tumor microenvironment: a pitch for multiple players. Front Oncol 2013; 3:90; http://dx.doi.org/10.3389/fonc.2013.00090; PMID: 23616948
- Holtschke T, Löhler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 1996; 87:307 - 17; http://dx.doi.org/10.1016/S0092-8674(00)81348-3; PMID: 8861914
- Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, Morse HC 3rd, et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med 2002; 196:1415 - 25; http://dx.doi.org/10.1084/jem.20021263; PMID: 12461077
- Tamura T, Kong HJ, Tunyaplin C, Tsujimura H, Calame K, Ozato K. ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells. Blood 2003; 102:4547 - 54; http://dx.doi.org/10.1182/blood-2003-01-0291; PMID: 12933588
- Abrams SI. A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology. Immunol Res 2010; 46:59 - 71; http://dx.doi.org/10.1007/s12026-009-8125-6; PMID: 19756408
- Mattei F, Schiavoni G, Sestili P, Spadaro F, Fragale A, Sistigu A, et al. IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment. Neoplasia 2012; 14:1223 - 35; PMID: 23308054
- Hu X, Bardhan K, Paschall AV, Yang D, Waller JL, Park MA, et al. Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid- Derived Suppressive Cells and Contributes to their Persistence in Tumors. J Biol Chem 2013; In press http://dx.doi.org/10.1074/jbc.M112.434530; PMID: 23677993
- Businaro L, De Ninno A, Schiavoni G, Lucarini V, Ciasca G, Gerardino A, et al. Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. Lab Chip 2013; 13:229 - 39; http://dx.doi.org/10.1039/c2lc40887b; PMID: 23108434
- Yoshimoto T, Morishima N, Mizoguchi I, Shimizu M, Nagai H, Oniki S, et al. Antiproliferative activity of IL-27 on melanoma. J Immunol 2008; 180:6527 - 35; PMID: 18453571
- Ksienzyk A, Neumann B, Nandakumar R, Finsterbusch K, Grashoff M, Zawatzky R, et al. IRF-1 expression is essential for natural killer cells to suppress metastasis. Cancer Res 2011; 71:6410 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-11-1565; PMID: 21900395